Alpine Immune Sciences Dividend
Dividend criteria checks 0/6
Alpine Immune Sciences no tiene antecedentes de pago de dividendos.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$0.49 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts
Mar 21
Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation
Mar 20Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug
Mar 07Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) Shares Climb 41% But Its Business Is Yet to Catch Up
Feb 07Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) 41% Share Price Surge Not Quite Adding Up
Dec 19We Think Alpine Immune Sciences (NASDAQ:ALPN) Can Afford To Drive Business Growth
Sep 23Revenues Not Telling The Story For Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
May 11Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?
Dec 12Alpine Immune Sciences drops 13% after hours on $100M stock offering
Sep 20Despite Lacking Profits Alpine Immune Sciences (NASDAQ:ALPN) Seems To Be On Top Of Its Debt
Aug 09Alpine: Rest Before Rallying Again
Apr 25Is Alpine Immune Sciences (NASDAQ:ALPN) A Risky Investment?
Apr 12Rock star Growth Puts Alpine Immune Sciences (NASDAQ:ALPN) In A Position To Use Debt
Sep 18Industry Analysts Just Upgraded Their Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Revenue Forecasts By 42%
Aug 18We Think The Compensation For Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) CEO Looks About Right
Jun 03Alpine Immune Sciences files for $150M mixed shelf offering
May 26Alpine Immune Sciences (NASDAQ:ALPN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Mar 29How Many Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Did Insiders Buy, In The Last Year?
Mar 03The Alpine Immune Sciences (NASDAQ:ALPN) Share Price Is Up 316% And Shareholders Are Delighted
Feb 05What Kind Of Shareholders Own Alpine Immune Sciences, Inc. (NASDAQ:ALPN)?
Jan 10
Alpine: Is This A Young Oak Tree?
Jan 05Does Alpine Immune Sciences (NASDAQ:ALPN) Have A Healthy Balance Sheet?
Dec 15Stability and Growth of Payments
Fetching dividends data
Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de ALPN han sido estables en el pasado.
Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de ALPN han aumentado.
Dividend Yield vs Market
| Alpine Immune Sciences Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ALPN) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Biotechs) | 2.7% |
| Analyst forecast in 3 Years (ALPN) | n/a |
Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de ALPN en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.
Alto dividendo: No es posible evaluar la rentabilidad por dividendo de ALPN en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.
Earnings Payout to Shareholders
Cobertura de los beneficios: No hay datos suficientes para calcular el ratio de reparto de ALPN para determinar si sus dividendos están cubiertos por los beneficios.
Cash Payout to Shareholders
Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que ALPN no ha comunicado ningún pago.